patent expiry

Patients

pharmaphorum podcast Episode 263, Rebecca Guntern - Sandoz

Biosimilars & patient access independent of geographies or s...

Rebecca Guntern, Sandoz' CCO, discusses the ‘golden decade’ for generics and biosimilars as so many blockbuster drugs come off patent.

R&D

Sandoz on the future of generics and biosimilars in Europe

At Reuters Pharma Europe, Sandoz' Claire D'Abreu-Hayling explored the promise of the so-called “golden decade” of patent expiry for generics.

News

MSD splits pharma business, hiving off oncology

MSD is separating its cancer and non-cancer pharma operations as it prepares for the looming loss of patent protection for $31bn blockbuster Keytruda.

News

Novartis sheds staff as Entresto patent expiry looms

Novartis will cut 427 jobs this year in the US as it prepares for the loss of market exclusivity for its blockbuster heart failure therapy Entresto.

News

an older man's hand with a pill in his palm

FDA approves first generics of anticoagulant Xarelto

The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto.

News

BMS extends its cost-cutting drive by another $2bn

BMS is extending its bid to cut costs by $1.5bn before the end of this year, backed by 2200 job cuts, adding a target of another $2bn by end-2027.

Biosimilars & patient access independent of geographies or s...

Sandoz on the future of generics and biosimilars in Europe

MSD splits pharma business, hiving off oncology

Novartis sheds staff as Entresto patent expiry looms

FDA approves first generics of anticoagulant Xarelto

BMS extends its cost-cutting drive by another $2bn

uniQure sets course to US filing for Huntington gene therapy

Discover a new era of healthcare panel engagement: Grounded ...

patent expiry

Editor's Picks